[Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)].
暂无分享,去创建一个
C. Delbaldo | V. Launay | E. Giroux | I. Bonnet | M. Favier | Fabienne Le Goc-Sager | Isabelle Vincent-Cantini | Katia Lièvremont | C. Barbe | Eléa Duval | Nathanael Loric